Northeast Financial Consultants’s Novartis NVS Stock Holding History

Northeast Financial Consultants’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,900	Closed	-$651K	–	303
2020 Q1	$651K	Hold	7,900	–	–	0.07%	150
2019 Q4	$748K	Sell	7,900 -156	-2%	-$14K	0.07%	152
2019 Q3	$700K	Hold	8,056	–	–	0.07%	157
2019 Q2	$736K	Sell	8,056 -934	-10%	-$79K	0.08%	152
2019 Q1	$775K	Buy	+8,990	New	+$722K	0.09%	140
2016 Q3	–	Sell	-2,790	Closed	-$206K	–	160
2016 Q2	$206K	Buy	+2,790	New	+$193K	0.09%	138
2016 Q1	–	Sell	-2,790	Closed	-$215K	–	138
2015 Q4	$215K	Hold	2,790	–	–	0.11%	116
2015 Q3	$230K	Hold	2,790	–	–	0.12%	118
2015 Q2	$246K	Hold	2,790	–	–	0.11%	127
2015 Q1	$247K	Hold	2,790	–	–	0.11%	117
2014 Q4	$232K	Hold	2,790	–	–	0.12%	114
2014 Q3	$235K	Hold	2,790	–	–	0.13%	116
2014 Q2	$226K	Hold	2,790	–	–	0.13%	112
2014 Q1	$213K	Hold	2,790	–	–	0.13%	111
2013 Q4	$201K	Buy	+2,790	New	+$194K	0.13%	97

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Northeast Financial Consultants's NVS Position: Q2 2020 in Review

Northeast Financial Consultants sold out of Novartis (NVS) in Q2 2020, closing a stake of 7,900 shares — an estimated $651K sold.

Northeast Financial Consultants first reported a position in NVS in Q4 2013 and held it in 15 quarters. The position peaked at $775K in Q1 2019. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Northeast Financial Consultants reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
Northeast Financial Consultants sold 7,900 Novartis shares in Q2 2020, an estimated $651K.
Northeast Financial Consultants first reported a position in Novartis in Q4 2013 and held it in 15 quarters.
Northeast Financial Consultants's Novartis position peaked at $775K in Q1 2019.
1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Northeast Financial Consultants's 13F filing for Q2 2020, filed 30 Jul 2020.